Table 1

Overview of the results for proteinase 3 (PR3)-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase (MPO)-ANCA obtained by immunoassays from different commercial sources1–8 and for cytoplasmic pattern ANCA (C-ANCA) and perinuclear pattern ANCA (P-ANCA) by indirect immunofluorescence (IIF) performed at two sites (Copenhagen (9) and Bad Bramstedt (10))

 Enzyme immunoassayIIF
PR3MPO12345678910
Controls
n=924
NegNeg904893895883906897894872Neg725866
PosNeg713101066717C-ANCA2719
NegPos1015162811191933P-ANCA17234
PosPos33331242C-ANCA+P-ANCA00
A-ANCA5
GPA
n=186
NegNeg2221262028232125Neg3922
PosNeg148146140144140143145140C-ANCA119144
NegPos1615192218192018P-ANCA2720
PosPos04100104C-ANCA+P-ANCA10
MPA
n=65
NegNeg12885109616Neg46
PosNeg42333333C-ANCA34
NegPos4753545651525644P-ANCA5855
PosPos22011102C-ANCA+P-ANCA00
Accuracy*0.9540.9490.9460.9440.9520.9500.9510.9220.7940.927
  • Cut-off values proposed by the manufacturer were used.

  • The assays included were from Inova (QuantaLite (1) and QuantaFlash (2)), Thermo-Fisher (EliA) (3), Bio-Rad (BioPlex 2200) (4), Euro-Diagnostica (5), Orgentec (6), Euroimmun (7) and Medipan (CytoBead assay) (8).

  • *Accuracy was calculated as follows: Embedded Image

  • A-ANCA, atypical ANCA; GPA, granulomatosis with polyangiitis; MPA, microscopic polyangiitis; MPO, myeloperoxidase; Neg, negative; Pos, positive.